-
Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight
29 Jul 2025 17:00 GMT
… secured a $10.2 million grant from the Cancer Prevention and … in adults with ACC. The grant spans three years and requires … including Corcept Therapeutics, Crinetics Pharmaceuticals, Cyclacel Pharmaceuticals, Sparrow Pharmaceuticals, Stero Therapeutics, among …
-
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
26 Jun 2024 13:15 GMT
… 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP … Office of the intention to grant a patent which includes claims … or otherwise. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 Mar 2021 21:01 GMT
… 11, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … addition, the Company intends to grant the underwriters a 30-day … assad@russopartnersllc.com © Copyright 2021 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical Officer
23 Oct 2020 20:30 GMT
… Board of Directors authorized the grant to Dr. Kirschbaum of non … 5635(c)(4). The inducement grant is exercisable at a price … stock option agreement. About Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical …
-
Cyclacel Pharmaceuticals Announces Collaboration With the University of Edinburgh to Study Its CDK Inhibitors to Reduce Runaway Inflammation in COVID-19 Disease
20 Apr 2020 11:00 GMT
… (approximately $2.5 million) grant from LifeArc and the University … is currently enrolling. About Cyclacel Pharmaceuticals, Inc. Cyclacel Pharmaceuticals is a clinical-stage … –1626.
Contacts © Copyright 2020 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. …
-
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
27 Mar 2019 20:13 GMT
… for 7 days.
About Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals is a clinical-stage … (R) are trademarks of Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS OF … 31,
2017 2018
Revenues:
Grant revenue $ - $ - …
-
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
27 Mar 2019 20:05 GMT
… and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS OF …
December 31,
2017
2018
Revenues:
Grant revenue
$
-
$
- …
-
Cyclacel Pharmaceuticals and MD Anderson Cancer Center Announce Strategic Alliance to Study Novel Cyclacel Medicines in Hematological Malignancies
04 Oct 2018 11:00 GMT
… are in development. About Cyclacel Pharmaceuticals, Inc. Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical … receives a cancer center support grant from the NCI of the … -enabling studies, funded by a grant of approximately $3.7 million …
-
Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results
09 Aug 2018 20:05 GMT
… and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS OF … ,
2017
2018
2017
2018
Revenues:
Grant revenue
$
-
$
- …
-
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
28 Mar 2018 20:05 GMT
… previously awarded, UK government grants being recognized over the … ® are trademarks of Cyclacel Pharmaceuticals, Inc. CYCLACEL PHARMACEUTICALS, INC.CONSOLIDATED STATEMENTS …
2016
2017
Revenues:
Grant revenue
$
843
$
- …
About
© 1995-2025